Neogen Correlations
NEOG Stock | USD 5.52 0.31 5.95% |
The current 90-days correlation between Neogen and Qiagen NV is -0.04 (i.e., Good diversification). The correlation of Neogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Neogen Correlation With Market
Good diversification
The correlation between Neogen and DJI is -0.16 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neogen and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Neogen Stock
0.81 | BMRA | Biomerica | PairCorr |
0.85 | EWTX | Edgewise Therapeutics | PairCorr |
0.88 | BMY | Bristol Myers Squibb | PairCorr |
0.73 | JNJ | Johnson Johnson | PairCorr |
0.84 | MRK | Merck Company Aggressive Push | PairCorr |
0.85 | PFE | Pfizer Inc | PairCorr |
0.61 | GILD | Gilead Sciences | PairCorr |
0.67 | GLUE | Monte Rosa Therapeutics | PairCorr |
0.73 | PMVP | Pmv Pharmaceuticals | PairCorr |
0.71 | RAPT | RAPT Therapeutics | PairCorr |
0.74 | HUMAW | Humacyte | PairCorr |
0.85 | ABBV | AbbVie Inc | PairCorr |
0.83 | AMGN | Amgen Inc Sell-off Trend | PairCorr |
0.76 | CCCC | C4 Therapeutics | PairCorr |
0.68 | DAWN | Day One Biopharmaceu | PairCorr |
0.86 | BAC-PL | Bank of America | PairCorr |
Moving against Neogen Stock
0.82 | PHIO | Phio Pharmaceuticals Corp | PairCorr |
0.79 | IVA | Inventiva Sa | PairCorr |
0.89 | NEM | Newmont Goldcorp Corp | PairCorr |
0.84 | TNYYF | Tinybeans Group | PairCorr |
0.75 | FE | FirstEnergy | PairCorr |
0.69 | BCH | Banco De Chile | PairCorr |
0.69 | HSPTU | Horizon Space Acquisition | PairCorr |
0.65 | VCICW | Vine Hill Capital | PairCorr |
0.55 | FNMFO | Federal National Mortgage | PairCorr |
0.55 | WF | Woori Financial Group | PairCorr |
0.53 | SHG | Shinhan Financial | PairCorr |
0.51 | LIDR | Aeye Inc | PairCorr |
0.5 | KB | KB Financial Group | PairCorr |
0.43 | STOK | Stoke Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Neogen Stock performing well and Neogen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Neogen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
QGEN | 1.44 | 0.27 | 0.15 | 0.33 | 1.58 | 4.59 | 10.08 | |||
OLK | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ACRS | 3.30 | (0.20) | 0.00 | (0.24) | 0.00 | 7.38 | 19.29 | |||
SYNH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
IQV | 2.17 | (0.26) | 0.00 | (0.20) | 0.00 | 3.69 | 17.46 | |||
MEDP | 2.24 | (0.12) | 0.00 | (0.10) | 0.00 | 4.53 | 15.82 | |||
ICLR | 2.18 | (0.40) | 0.00 | (0.34) | 0.00 | 4.37 | 17.38 | |||
SHC | 2.07 | 0.10 | 0.04 | 0.07 | 2.52 | 3.96 | 21.87 | |||
RDNT | 2.17 | 0.19 | 0.08 | 0.15 | 2.35 | 5.24 | 16.74 | |||
MYGN | 4.00 | (0.80) | 0.00 | (0.68) | 0.00 | 8.40 | 50.58 |
Neogen Corporate Management
John Moylan | Corporate VP | Profile | |
Bill Waelke | Head Relations | Profile | |
Dr MBA | Chief Officer | Profile | |
Julie Mann | VP Officer | Profile | |
Amy Rocklin | Chief Secretary | Profile | |
David Naemura | Chief Officer | Profile |